A new JADPRO CE supplement on the management of immune-related adverse events, Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events.
In this introductory section, guest editor Brianna Hoffner, MSN, ANP-BC, AOCNP®, discusses the origin of the IO Essentials Initiation and provides an overview of this supplement.
Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
In this article, Brianna Hoffner, MSN, ANP-BC, AOCNP®, and Krista M. Rubin, MS, FNP-BC, discuss the steps advanced practice providers can take to optimize irAE management and reduce unplanned hospital admissions through enhanced telephone triage and incorporation of dedicated oncology acute care tactics.
PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
In this article, Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP®, discusses the incorporation of ICIs in the treatment of lung cancer, with a focus on irAEs that are particularly challenging in this setting, including pneumonitis.
This article, authored by Casey Fazer, PA-C , addresses irAE management in HNSCC and includes a discussion of nutrition, thyroiditis, and mucositis/xerostomia, which are particularly salient in this population.
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
In this article, Laura S. Wood, RN, MSN, OCN®, provides an overview of irAE management across tumor types, with a particular focus on specific challenges in renal cell carcinoma, including nephritis and diarrhea/colitis.
The appendix contains the 12 Care Step Pathways for irAE assessment, grading, and management that are discussed in the articles.